Quantitative Thresholds of MHC Class II I-E Expressed on Hemopoietically Derived Antigen-Presenting Cells in Transgenic NOD/Lt Mice Determine Level of Diabetes Resistance and Indicate Mechanism of Protection

Journal of Immunology

Volumn 157, Issue 3, 1996, Pages 1279-1287

  Hanson, Matthew S ^a   Cetkovic Cvrlje, Marina ^a   Ramiya, Vijayakumar K ^b   Atkinson, Mark A ^b   Maclaren, Noel K ^b   Singh, Bhagirath ^c   Elliott, John F ^d   Serreze, David V ^a   Leiter, Edward H ^a  

^a JACKSON LABORATORY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GLUTAMATE DECARBOXYLASE; HLA ANTIGEN CLASS 2; I E ANTIGEN; I-E-ANTIGEN; INTERLEUKIN 4; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

AMINO ACID SEQUENCE; ANIMAL; ANTIGEN PRESENTING CELL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; MOLECULAR GENETICS; MOUSE; NONOBESE DIABETIC MOUSE; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TRANSGENE; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-PRESENTING CELLS; AUTOANTIGENS; BLOTTING, NORTHERN; DEOXYRIBONUCLEASE HINDIII; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLUTAMATE DECARBOXYLASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, NATURAL; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSGENES;

EID: 0030209820     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Cahill, G., and H. McDevitt. 1981. Insulin-dependent diabetes mellitus: the initial lesion. N. Engl. J. Med. 304:1454.
2. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese, diabetic strain of mice. Exp. Anim. 29:1.
3. Serreze, D. 1993. Autoimmune diabetes results from genetic defects manifest by antigen-presenting cells. FASEB J. 7:1092.
4. Serreze, D., and E. Leiter. 1994. Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr. Opin. Immunol. 6:900.
5. Acha-Orbea, H., and H. McDevitt. 1987. The first external domain of the nonobese diabetic mouse class II I-Aβ chain is unique. Proc. Natl. Acad. Sci. USA 84:2435.
6. Todd, J., J. Bell, and H. McDevitt. 1987. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599.
7. Hattori, M., J. Buse, R. Jackson, L. Glimcher, M. Dorf, M. Minami, S. Makino, K. Moriwaki, H. Kuzuya, H. Imura, W. Strauss, J. Seidman, and G. Eisenbarth. 1986. The NOD mouse: recessive diabetogenic gene within the major histocompatibility complex of the non-obese diabetic mouse. Science 231:733.
8. Nishimoto, H., H. Kikutani, K. Yamamura, and T. Kishimoto. 1987. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 328:432.
9. Lund, T., L. O'Reilly, P. Hutchings, O. Kanagawa, E. Simpson, R. Gravely, P. Chandler, J. Dyson, J. Picard, A. Edwards, D. Kioussis, and A. Cooke. 1990. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain. Nature 345: 727.
10. Uno, M., T. Miyazaki, M. Uehira, H. Nishimoto, M. Kimoto, J. Miyazaki, and K. Yamamura. 1991. Complete prevention of diabetes in transgenic NOD mice expressing I-E molecules. Immunol. Lett. 31:47.
11. k transgenic mice. Nature 345:724.
12. Böhme, J., B. Shuhbaur, O. Kanagawa, C. Benoist, and D. Mathis. 1990. MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science 249:293.
13. Parish, N., P. Chandler, R. Quartey-Papafio, E. Simpson, and E. Cooke. 1993. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes. Eur. J. Immunol. 23:2667.
14. Merino, R., M. Iwamoto, L. Fossati, P. Muniesa, K. Araki, S. Takahashi, J. Huarte, K. Yamamura, J. Vassili, and S. Izui. 1993. Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding I-E α-chain. J. Exp. Med. 178:1189.
15. Deng, H., R. Apple, M. Clare-Salzer, S. Trembleau, D. Mathis, L. Adorini, and E. Sercarz. 1993. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J. Exp. Med. 178:1675.
16. d transgene prevents diabetes in NOD mice by inducing regulatory T cells. Proc. Natl. Acad. Sci. USA 90:9566.
17. Rapoport, M., J. A. Jaramillo, D. Zipris, A. H. Lazarus, D. V. Serreze, E. H. Leiter, P. Cyopick, J. S. Danska, and T. L. Delovitch. 1993. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in non-obese diabetic mice. J. Exp. Med. 178:87.
18. Qin, H., M. Sadelain, C. Hitchon, J. Lauzon, and B. Singh. 1993. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J. Immunol. 150:2072.
19. Singh, B., and A. Rabinovitch. 1993. Influence of microbial agents on the development and prevention of autoimmune diabetes. Autoimmunity 15:209.
20. + suppressor T cells in superantigen-treated non-obese diabetic mice. J. Immunol. 151:4362.
21. Petersen, J., A. Karlsen, H. Markholst, A. Worsaae, T. Dyrberg, and B. Michelsen. 1994. Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes 44:1478.
22. Pfeiffer, C., J. Murray, J. Madri, and K. Bottomly. 1991. Selective activation of Th1- and Th2-like cells in vivo: response to human collagen IV. Immunol. Rev. 123:65.
23. Prochazka, M., H. Gaskins, L. Shultz, and E. Leiter. 1992. The NOD-scid mouse: a model for spontaneous thymomagenesis associated with immunodeficiency. Proc. Natl. Acad. Sci. USA 89:3290.
24. Steinmetz, M., K. Minard, S. Horvath, J. McNicholas, J. Srelinger, C. Wake, E. Long, B. Mach, and L. Hood. 1982. A molecular map of the immune response region from the major histocompatibility complex of the mouse. Nature 300:35.
25. Leiter, E. 1987. Murine macrophages and pancreatic β cells: chemotactic properties of insulin and β-cytostatic action of interleukin-1. J. Exp. Med. 166:1174.
26. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
27. Gaskins, H., M. Prochazka, K. Hamaguchi, D. Serreze, and E. Leiter. 1992. Beta cell expression of endogenous xenotropic retrovirus distinguishes diabetes-susceptible NOD/Lt from resistant NON/Lt mice. J. Clin. Invest. 90:2220.
28. 67) prevents autoimmune diabetes in NOD mice. Diabetes 43: 1494.
29. Kaufman, D., M. Clare-Salzler, J. Tian, T. Forsthuber, G. Ting, P. Robinson, M. Atkinson, E. Sercarz, A. Tobin, and P. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69.
30. Fujishima, Y., Y. Kaidoh, M. Nishimura, and T. Yoshida. 1989. Restriction fragment length polymorphism analysis of major histocompatibility complex genes in the non-obese diabetic mouse strain and its non-diabetic sister strains. Diabetologia 32:118.
31. Harada, M., and S. Makino. 1984. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia 27:604.
32. Tisch, R., X. Yang, S. Singer, R. Liblau, L. Fugger, and H. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulins in non-obese diabetic mice. Nature 366:72.
33. d gene expression in C57BL/6 transgenic mice. Immunology 65:589.
34. + nonobese diabetic mice develop insulitis and diabetes. J. Exp. Med. 178:1189.
35. g7 molecules from nonobese diabetic mice are poor peptide binders. J. Immunol. 156:450.
36. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16:34.
37. Trembleau, S., G. Penna, E. Bosi, A. Mortara, M. Gately, and L. Adorini. 1995. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817.
38. Kaye, P., A. Cooke, T. Lund, M. Waitte, and J. Blackwell. 1992. Altered course of visceral leishmaniasis in mice expressing I-E molecules. Ear. J. Immunol. 22:357.
39. Takacs, K., D. Douek, and D. Altmann. 1995. Exacerbated autoimmunity associated with a T helper-1 cytokine profile shift in H-2E-transgenic mice. Eur. J. Immunol. 25:3134.
40. Viner, N. I., C. A. Nelson, B. Deck, and E. R. Unanue. 1996. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing. J. Immunol. 156:2365.
41. Atkinson, M., M. Bowman, L. Campbell, B. Darrow, D. Kaufman, and N. MacLaren. 1994. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackievirus in insulin-dependent diabetes. J. Clin. Invest. 94:2125.
42. Lohmann, T., R. Leslie, M. Hawa, M. Geysen, S. Rodda, and M. Londei. 1994. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet 343:1607.
43. Kelso, A. 1995. Th1 and Th2 subsets: paradigms lost? Immunol. Today 16:374.
44. Serreze, D. V., K. Hamaguchi, and E. H. Leiter. 1990. Immunostimulation circumvents diabetes in NOD/Lt mice. J. Autoimmun. 2:759.